It takes approximately between 2 and 6 weeks from the beginning of Aranesp® therapy for your anemia to get better.1 This means that the sooner you are aware of your anemia management options, the better prepared you’ll be to start treatment if you need it.
When undergoing chemotherapy in the past, did you experience anemia? In many people with cancer who are receiving chemotherapy, once hemoglobin levels begin to fall, they can continue to decrease. In a clinical study, it was shown that 35% of patients had a decrease in their hemoglobin levels (from below 10 g/dL to below 9 g/dL) within 3 weeks of chemotherapy.2
If you think you may have anemia, it’s important to speak to your healthcare team right away. The symptoms of anemia may start off as mild and can be similar to other conditions or to the side effects of chemotherapy. Talk to your healthcare provider about anemia when receiving chemotherapy, especially if you are experiencing3,4:
Yes—chemotherapy is known to be a cause of anemia. The job of chemotherapy is to destroy fast-growing cells, such as tumor cells. Due to its effectiveness at doing just this, it can sometimes kill friendly cells, such as the cells that produce your red blood cells. When you have a lower than normal number of red blood cells, this is called anemia.3
Red blood cells contain hemoglobin (hee-moh-glow-bin), a protein that carries oxygen to your organs and tissues. Without the right amount of hemoglobin, your muscles and organs may not be getting enough oxygen to function properly.5
Aranesp® may cause serious side effects that can lead to death, including:
If you decide to take Aranesp®, your healthcare provider should prescribe the smallest dose that is necessary to reduce your chance of needing RBC transfusions.
If your hemoglobin level stays too high or goes up too quickly, this may lead to serious health problems which may result in death. These serious health problems may happen if you take Aranesp®, even if you do not have an increase in your hemoglobin level.
Before taking Aranesp®, tell your doctor if you: have heart disease; have high blood pressure; have had a seizure or stroke; or if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
If you know you are allergic to latex, talk to your healthcare provider before using Aranesp® because the needle cover on the prefilled syringe contains latex.
These are not all the possible side effects of ARANESP®. Tell your healthcare provider about any side effects that bother you or do not go away.
You are encouraged to report negative side effects of prescription drugs to the US Food and Drug Administration (FDA). Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chronic kidney disease in patients on dialysis and not on dialysis.
Aranesp® is a prescription medicine used to treat a lower than normal number of red blood cells (anemia) caused by chemotherapy that will be used for at least two months after starting Aranesp®.
Aranesp® has not been proven to improve quality of life, fatigue, or well-being.
Aranesp® should not be used for the treatment of anemia: